Home › Entities › clinical_trial › Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

clinical trial
MedicalStudy clinical_trial Q66080117
Press Enter · cited answer in seconds

Summary

Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) is a clinical trial[1].

Key Facts

  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) is in the country of United States[2].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s instance of is recorded as clinical trial[3].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s start time is recorded as +2017-07-03T00:00:00Z[4].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s end time is recorded as +2021-02-28T00:00:00Z[5].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s sponsor is recorded as Medical College of Wisconsin[6].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s main subject is recorded as anemia[7].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s number of participants is recorded as {'unit': '1', 'amount': '+30'}[8].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s title is recorded as Optimizing Haploidentical Aplastic Anemia Transplantation (CHAMP) (BMT CTN #1502)[9].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s short name is recorded as CHAMP[10].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s ClinicalTrials.gov ID is recorded as NCT02918292[11].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[12].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s research intervention is recorded as (RS)-cyclophosphamide[13].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s research intervention is recorded as fludarabine phosphate[14].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s clinical trial phase is recorded as phase II clinical trial[15].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s research site is recorded as Stanford University[16].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s research site is recorded as Children's National Hospital[17].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s research site is recorded as Roswell Park Comprehensive Cancer Center[18].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s research site is recorded as Oregon Health and Science University[19].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s research site is recorded as Fred Hutchinson Cancer Center[20].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s research site is recorded as City of Hope National Medical Center[21].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s research site is recorded as University of South Florida[22].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s research site is recorded as Duke University Medical Center[23].
  • Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)'s study type is recorded as interventional study[24].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.
  19. [20] ↑ . wikidata.org.
  20. [21] ↑ . wikidata.org.
  21. [22] ↑ . wikidata.org.
  22. [23] ↑ . wikidata.org.
  23. [24] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502). Retrieved May 3, 2026, from https://4ort.xyz/entity/optimizing-haploidentical-aplastic-anemia-transplantation-bmt-ctn-1502-
MLA “Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502).” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/optimizing-haploidentical-aplastic-anemia-transplantation-bmt-ctn-1502-.
BibTeX @misc{4ortxyz_optimizing-haploidentical-aplastic-anemia-transplantation-bmt-ctn-1502-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)}}, year = {2026}, url = {https://4ort.xyz/entity/optimizing-haploidentical-aplastic-anemia-transplantation-bmt-ctn-1502-}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) — https://4ort.xyz/entity/optimizing-haploidentical-aplastic-anemia-transplantation-bmt-ctn-1502- (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/optimizing-haploidentical-aplastic-anemia-transplantation-bmt-ctn-1502- · Last refreshed: